EVERY Company Secures $55 Million in Funding
The EVERY Company has secured $55 million in a Series D funding round, led by McWin Capital Partners, with participation from investors including Main Sequence, Bloom8, and Minerva Foods.
This funding will support the company's expansion into the US market as it scales up its production of precision-fermented egg proteins.
EVERY is proving that biomanufacturing has the potential to transform the food industry
Alternative to Traditional Egg Proteins
EVERY's fermentation-based technology has gained significant attention as an alternative to traditional egg proteins, with offerings such as OvoPro™ and OvoBoost™ designed to replace conventional eggs in products across sectors.
- OvoPro™: a substitute for egg whites
- OvoBoost™: a neutral protein for various food and beverage applications
Author's summary: EVERY Company secures $55M funding.
More News
- Toronto Tempo Wins the Sandy Brondello Sweepstakes
- What's on the ballot in the first general election since Donald Trump became president
- Canada's immigration system is lost in the bushes
- Mexican Authorities Suspect That Mayor Was Killed By The Jalisco Cartel: Report
- All proceedings to be moved out of Pikeville federal courthouse - Mountain Top Media
- Tech Soccer achieves four-peat
- Pike man arrested for breaking into home, threatening woman - Mountain Top Media
- High wind Warning Issued for Our Area - Sonoma Valley Sun
- "Moore keeps redistricting push alive in Maryland amid national map fights" #ELB
- Anonymous Crypto Swaps: How Privacy-First Exchanges Are Redefining Trading in 2025